Navigation Links
Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
Date:10/23/2007

n it?' Leksell Gamma Knife Perfexion is the representation of that partnership - it was redesigned from the ground up, based on a lot of user experience. The medical device industry does not always do that, but in this case, Elekta asked the users to design the product."

Technological advances are a leap forward

Dr. Lunsford says the team had a tall order to fill. "We wanted to increase the volume of the brain, neck and upper spine that could be treated, reduce radiation exposure to patients and staff, improve how conformally and selectively we could confine the dose delivery to every target, increase patient comfort during the procedure, improve patient flow, and maximize the precision of the robotic positioning system. All of these issues were solved with the Leksell Gamma Knife Perfexion. Our hopes and expectations have been surpassed by the actual product."

Dr. Lunsford says Leksell Gamma Knife Perfexion is a robust, reliable and extremely versatile radiosurgical device. "The actual procedure is exceedingly fast, so treatment times are much shorter. Because of the redesign, patients can now be treated in a neutral neck position, and the bed is much wider as well."

Leksell Gamma Knife Perfexion technology is an enormous advance in brain radiosurgery, says Dr. Lunsford, and a huge leap forward in the field. "Among the many applications that have been performed by Gamma Knife is the increasing incidence of metastatic brain cancer. Leksell Gamma Knife Perfexion offers enormous opportunity to treat lesions all over the brain with excellent patient comfort in a single treatment," he says. "This will continue to change how metastatic brain cancer is treated around the world."

UPMC - Elekta partnership going strong

The University of Pittsburgh has been a primary collaboration site for many of Elekta's new technologies, from stereotactic frames to surgical planning systems. "We put in the first Leksell Gamma Knife in North America in 1
'/>"/>

SOURCE Elekta, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., ,, ANDOVER,Mass.,Nov.24/PRNewswire/--Visa...dicusLtd.(ASX:PME),willbeintroducingVisage®7,...on,attheAnnualConferenceoftheRadiologicSocietyofNo...go,IL. ,, Visage®7deliversnewlevelsofversa...ub-specialists,andreferringphysicians.TheVisage7Un...
(Date:11/24/2009)..., NEWYORK,Nov.24/PRNewswire/--AFOXThanksgivingDay...nofi-aventisU.S.remindsviewersthattheholidaysareat...stcancerandforallthosewhofightthatbattleeachdayass...lwillfeaturethehistoricreturntotheiceofcancersurvi...romOliviaNewton-JohnandDavidFosterwhowillperform"H...
(Date:11/23/2009)..., CINCINNATI,Nov.23/PRNewswire-FirstCall/--Health....S.mail-orderpharmacy,todayannounceditsfinancialre...mpanyreportedquarterlyrevenueof$1,006,721,drivenby....Grossmarginsincreased13.0%year-over-yearto34.6%an...ossof$186,299forthethreemonthsendedSeptember30,200...
Breaking Medicine Technology:Visage Imaging Introduces Visage(R) 7 for Windows and Mac OS X 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 3HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 3Orexigen 28R 29 Therapeutics to Speak at Upcoming Conferences 13930 1Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598 4957 1Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598 4957 2Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598 4957 3Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598 4957 4Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598 4957 5Providers of Packaging Design Security Printing and Track and Trace Technology Allign to Provide Multi Layered Brand Protection Solution 56527 1Providers of Packaging Design Security Printing and Track and Trace Technology Allign to Provide Multi Layered Brand Protection Solution 56527 2Providers of Packaging Design Security Printing and Track and Trace Technology Allign to Provide Multi Layered Brand Protection Solution 56527 3Providers of Packaging Design Security Printing and Track and Trace Technology Allign to Provide Multi Layered Brand Protection Solution 56527 4Providers of Packaging Design Security Printing and Track and Trace Technology Allign to Provide Multi Layered Brand Protection Solution 56527 5
... pipeline products highlight Watson,s commitment t...:10 PM EDT, ORLANDO, Fla., May 21 Watson Pharmac...harmaceutical company, announced,today that invest...ducts at,the American Urological Association,s ann...y trial involving silodosin, an investigational tr...
...ANCISCO, Calif., May 21 Sunesis,Pharmaceuticals, ...on of the,REVEAL-1 (Response Evaluation of Vorelox...oxin (also known as SNS-595), the company,s lead a...g conducted in previously untreated,elderly patien...ely to,benefit from standard induction therapy. Th...
Other Medicine Technology:Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 2Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 3Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 4Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 5Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 6Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 2Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 3Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 4Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 5
(Date:11/24/2009)...family members of pediatric cancer and hematology ...y and the medical team, according to a new Indiana...ospital for Children, where the study was conducte...nationwide routinely offering the parents of pedia...y to join their child,s medical team as active par...
(Date:11/24/2009)... those with undesirable blood levels, analysis sho... -- Abnormal cholesterol levels can significantly ...s found. , U.S. researchers analyzed data on 6,...Blood Institute,s Framingham Heart Study. None of ...rt disease at the start of the study. After about ...
(Date:11/24/2009)...Laser-type device to be coupled with Stem Cell The...WEB) November 24, 2009 -- Entest Biomedical, Inc....scussions with a manufacturer of lasers regarding ...h shall be owned by Entest and used in conjunction...developed by Entest. These therapies are aimed at ...
(Date:11/24/2009)...Web content and Internet marketing specialists rel...your website. , (PRWEB) N...ar for the U.S. economy. Small business owners acr...ep their businesses afloat and reduce costs. Typic...ngs like training or marketing programs that aren&...
(Date:11/24/2009)...S-1RegistrationStatementbeingPreparedbyLeadingLawF...,Nov.24/PRNewswire-FirstCall/--AmericanScientificR...edtomakeavailableacurrentcorporateupdate. ,, Si...ecently,ASRhasbeendiligentinaccomplishingadditiona...eCompany. ,, Aspartofthisongoingprocess,2009thi...
Breaking Medicine News(10 mins):Health News:Involving family in medical rounds benefits both family and medical team 2Health News:Involving family in medical rounds benefits both family and medical team 3Health News:Involving family in medical rounds benefits both family and medical team 4Health News:Cholesterol Plays Role in Heart Failure Risk 2Health News:Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment 2Health News:We Do Web Content Offers Free Lead Generation Report 2Health News:We Do Web Content Offers Free Lead Generation Report 3Health News:American Scientific Resources Inc. Issues Corporate Update 2Health News:American Scientific Resources Inc. Issues Corporate Update 3
...NSWICK, N.J., Dec. 11 Johnson & Johnson (NYSE... Director of the Antitrust Authority has approved ...rix Biopharmaceuticals, Inc. (Nasdaq: OMRI ), un...008. It commenced, through a new wholly-owned subs...
...OLIS, Dec. 11 Bioenergy Life Science -- The Ribos...to Solutions, LLC, to market,Bioenergy D-Ribose(TM...rring,monosaccharide the body uses to stimulate th...d,expanding D-Ribose into the marketplace," said K...
...OR, Mich., Dec. 11 Three more Michigan start-up,c...through the Michigan,Pre-Seed Capital Fund: Arbor ... 28 Michigan companies have received a combined ...gan Pre-Seed Capital Fund has had consistent deal ...
...ROCK, Ark., Dec. 11 Travel Nurse across America h...for healthcare staffing,services from The Joint Co...ational supplemental healthcare staffing,firm, rec...petency of their traveling nurses and surgical tec...
...AS, Dec. 11 American Pacific Corporation,(Nasdaq:... fiscal 2008 fourth,quarter and year ended Septemb...as a supplement to financial results based on,GAAP...FINANCIAL HIGHLIGHTS , Quarter Ended Septemb...
...ANTONIO - Scientists in the clinic and the laborat...ity rates down with breakthrough drugs. With tamox...t of Herceptin still being felt, researchers are s...CR San Antonio Breast Cancer Symposium. , , Zo...
Other Medicine News:Health News:Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of Omrix 2Health News:Bioenergy Life Science Retains Xsto Solutions to Market D-Ribose 2Health News:Michigan Pre-Seed Capital Fund Invests in Three More Michigan Start-Ups 2Health News:Travel Nurse Across America Awarded Certification From The Joint Commission 2Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 2Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 3Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 4Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 5Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 6Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 7Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 8Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 9Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 10Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 11Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 12Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 13Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 14Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 15Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 16Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 17Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 18Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 19Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 20Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 21Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 22Health News:Cancer drugs in the pipeline 2
Slimtine S
M 3.2 J Unipolar Atrial "J" Lead
VascoTip P 9/60 PU S
VascoTip P 9/60 M
Medicine Products: